Pharmacological intervention, targeting ATP, P2X4/P2X7, ROS, NF-κB, HMGB1, RAGE, CSE, H2S or Cav3.2, might serve as novel therapeutic strategies for treatment of bladder pain in IC/BPS patients. The gene discussed is HMGB1; the disease is Bartsocas-Papas syndrome 1.